NCT03199703View on ClinicalTrials.gov

Conventional Versus RF Needle Transseptal Puncture for Cryoballoon Ablation

NACompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

January 17, 2017

Primary Completion Date

May 17, 2019

Study Completion Date

August 1, 2020

Conditions
Atrial Fibrillation
Interventions
DEVICE

Baylis transseptal system group

DEVICE

Standard conventional transseptal group

Trial Locations (6)

Unknown

St. Paul's Hospital, Vancouver

Vancouver General Hospital, University of British Columbia, Vancouver

Queen Elizabeth II, Halifax

Southlake Regional Health Centre, Newmarket

Université Laval, Québec

University of Saskatchewan, Saskatoon

Sponsors

Collaborators (1)

Baylis Medical Company
All Listed Sponsors
collaborator

Baylis Medical Company

INDUSTRY

lead

Jason Andrade

OTHER

NCT03199703 - Conventional Versus RF Needle Transseptal Puncture for Cryoballoon Ablation | Biotech Hunter | Biotech Hunter